Suppression  ||| S:0 E:12 ||| NN
of  ||| S:12 E:15 ||| IN
TPA-induced  ||| S:15 E:27 ||| JJ
cancer  ||| S:27 E:34 ||| NN
cell  ||| S:34 E:39 ||| NN
invasion  ||| S:39 E:48 ||| NN
by  ||| S:48 E:51 ||| IN
Peucedanum  ||| S:51 E:62 ||| NNP
japonicum  ||| S:62 E:72 ||| VBD
Thunb.  ||| S:72 E:79 ||| CD
extract  ||| S:79 E:87 ||| NN
through  ||| S:87 E:95 ||| IN
the  ||| S:95 E:99 ||| DT
inhibition  ||| S:99 E:110 ||| NN
of  ||| S:110 E:113 ||| IN
PKCα ||| S:113 E:117 ||| NNP
/ ||| S:117 E:118 ||| NNP
NF-κB-dependent  ||| S:118 E:134 ||| NNP
MMP-9  ||| S:134 E:140 ||| NNP
expression  ||| S:140 E:151 ||| NN
in  ||| S:151 E:154 ||| IN
MCF-7  ||| S:154 E:160 ||| CD
cells  ||| S:160 E:166 ||| NNS
Metastatic  ||| S:166 E:177 ||| JJ
cancers  ||| S:177 E:185 ||| NNS
spread  ||| S:185 E:192 ||| VBN
from  ||| S:192 E:197 ||| IN
their  ||| S:197 E:203 ||| PRP$
site  ||| S:203 E:208 ||| NN
of  ||| S:208 E:211 ||| IN
origin  ||| S:211 E:218 ||| NN
( ||| S:218 E:219 ||| -LRB-
the  ||| S:219 E:223 ||| DT
primary  ||| S:223 E:231 ||| JJ
site ||| S:231 E:235 ||| NN
)  ||| S:235 E:237 ||| -RRB-
to  ||| S:237 E:240 ||| TO
other  ||| S:240 E:246 ||| JJ
parts  ||| S:246 E:252 ||| NNS
of  ||| S:252 E:255 ||| IN
the  ||| S:255 E:259 ||| DT
body ||| S:259 E:263 ||| NN
.  ||| S:263 E:265 ||| .
Matrix  ||| S:265 E:272 ||| NNP
metalloproteinase-9  ||| S:272 E:292 ||| NNP
( ||| S:292 E:293 ||| -LRB-
MMP-9 ||| S:293 E:298 ||| NNP
) ||| S:298 E:299 ||| -RRB-
,  ||| S:299 E:301 ||| ,
which  ||| S:301 E:307 ||| WDT
degrades  ||| S:307 E:316 ||| VBZ
the  ||| S:316 E:320 ||| DT
extracellular  ||| S:320 E:334 ||| JJ
matrix ||| S:334 E:340 ||| NN
,  ||| S:340 E:342 ||| ,
is  ||| S:342 E:345 ||| VBZ
important  ||| S:345 E:355 ||| JJ
in  ||| S:355 E:358 ||| IN
metastatic  ||| S:358 E:369 ||| JJ
cancers  ||| S:369 E:377 ||| NNS
as  ||| S:377 E:380 ||| IN
it  ||| S:380 E:383 ||| PRP
plays  ||| S:383 E:389 ||| VBZ
a  ||| S:389 E:391 ||| DT
major  ||| S:391 E:397 ||| JJ
role  ||| S:397 E:402 ||| NN
in  ||| S:402 E:405 ||| IN
cancer  ||| S:405 E:412 ||| NN
cell  ||| S:412 E:417 ||| NN
invasion ||| S:417 E:425 ||| NN
.  ||| S:425 E:427 ||| .
The  ||| S:427 E:431 ||| DT
present  ||| S:431 E:439 ||| JJ
study  ||| S:439 E:445 ||| NN
examined  ||| S:445 E:454 ||| VBD
the  ||| S:454 E:458 ||| DT
inhibitory  ||| S:458 E:469 ||| JJ
effect  ||| S:469 E:476 ||| NN
of  ||| S:476 E:479 ||| IN
an  ||| S:479 E:482 ||| DT
ethanol  ||| S:482 E:490 ||| JJ
extract  ||| S:490 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
Peucedanum  ||| S:501 E:512 ||| NNP
japonicum  ||| S:512 E:522 ||| FW
Thunb.  ||| S:522 E:529 ||| FW
( ||| S:529 E:530 ||| -LRB-
PJT ||| S:530 E:533 ||| NNP
)  ||| S:533 E:535 ||| -RRB-
on  ||| S:535 E:538 ||| IN
MMP-9  ||| S:538 E:544 ||| CD
expression  ||| S:544 E:555 ||| NN
and  ||| S:555 E:559 ||| CC
the  ||| S:559 E:563 ||| DT
invasion  ||| S:563 E:572 ||| NN
of  ||| S:572 E:575 ||| IN
MCF-7  ||| S:575 E:581 ||| CD
breast  ||| S:581 E:588 ||| NN
cancer  ||| S:588 E:595 ||| NN
cells  ||| S:595 E:601 ||| NNS
induced  ||| S:601 E:609 ||| VBN
by  ||| S:609 E:612 ||| IN
12-O-tetradecanoylphorbol-13-acetate  ||| S:612 E:649 ||| NNP
( ||| S:649 E:650 ||| -LRB-
TPA ||| S:650 E:653 ||| NNP
) ||| S:653 E:654 ||| -RRB-
.  ||| S:654 E:656 ||| .
Western  ||| S:656 E:664 ||| JJ
blot  ||| S:664 E:669 ||| JJ
analysis ||| S:669 E:677 ||| NN
,  ||| S:677 E:679 ||| ,
gelatin  ||| S:679 E:687 ||| JJ
zymography ||| S:687 E:697 ||| NN
,  ||| S:697 E:699 ||| ,
and  ||| S:699 E:703 ||| CC
reverse  ||| S:703 E:711 ||| VB
transcription-quantitative  ||| S:711 E:738 ||| JJ
PCR  ||| S:738 E:742 ||| NNP
revealed  ||| S:742 E:751 ||| VBD
that  ||| S:751 E:756 ||| IN
PJT  ||| S:756 E:760 ||| NNP
significantly  ||| S:760 E:774 ||| RB
suppressed  ||| S:774 E:785 ||| VBD
MMP-9  ||| S:785 E:791 ||| CD
expression  ||| S:791 E:802 ||| NN
and  ||| S:802 E:806 ||| CC
activation  ||| S:806 E:817 ||| NN
in  ||| S:817 E:820 ||| IN
a  ||| S:820 E:822 ||| DT
dose-dependent  ||| S:822 E:837 ||| JJ
manner ||| S:837 E:843 ||| NN
.  ||| S:843 E:845 ||| .
Furthermore ||| S:845 E:856 ||| RB
,  ||| S:856 E:858 ||| ,
PJT  ||| S:858 E:862 ||| NNP
attenuated  ||| S:862 E:873 ||| VBD
TPA-induced  ||| S:873 E:885 ||| JJ
nuclear  ||| S:885 E:893 ||| JJ
translocation  ||| S:893 E:907 ||| NN
and  ||| S:907 E:911 ||| CC
the  ||| S:911 E:915 ||| DT
transcriptional  ||| S:915 E:931 ||| JJ
activation  ||| S:931 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
nuclear  ||| S:945 E:953 ||| JJ
factor  ||| S:953 E:960 ||| NNP
( ||| S:960 E:961 ||| -LRB-
NF ||| S:961 E:963 ||| NNP
) ||| S:963 E:964 ||| -RRB-
-κB ||| S:964 E:967 ||| JJ
.  ||| S:967 E:969 ||| .
The  ||| S:969 E:973 ||| DT
results  ||| S:973 E:981 ||| NNS
indicated  ||| S:981 E:991 ||| VBD
that  ||| S:991 E:996 ||| IN
the  ||| S:996 E:1000 ||| DT
PJT-mediated  ||| S:1000 E:1013 ||| JJ
inhibition  ||| S:1013 E:1024 ||| NN
of  ||| S:1024 E:1027 ||| IN
TPA-induced  ||| S:1027 E:1039 ||| JJ
MMP-9  ||| S:1039 E:1045 ||| CD
expression  ||| S:1045 E:1056 ||| NN
and  ||| S:1056 E:1060 ||| CC
cell  ||| S:1060 E:1065 ||| NN
invasion  ||| S:1065 E:1074 ||| VBZ
involved  ||| S:1074 E:1083 ||| VBN
the  ||| S:1083 E:1087 ||| DT
suppression  ||| S:1087 E:1099 ||| NN
of  ||| S:1099 E:1102 ||| IN
the  ||| S:1102 E:1106 ||| DT
PKCα ||| S:1106 E:1110 ||| JJ
/ ||| S:1110 E:1111 ||| CD
NF-κB  ||| S:1111 E:1117 ||| JJ
pathway  ||| S:1117 E:1125 ||| NN
in  ||| S:1125 E:1128 ||| IN
MCF-7  ||| S:1128 E:1134 ||| CD
cells ||| S:1134 E:1139 ||| NNS
.  ||| S:1139 E:1141 ||| .
Thus ||| S:1141 E:1145 ||| RB
,  ||| S:1145 E:1147 ||| ,
the  ||| S:1147 E:1151 ||| DT
inhibition  ||| S:1151 E:1162 ||| NN
of  ||| S:1162 E:1165 ||| IN
MMP-9  ||| S:1165 E:1171 ||| CD
expression  ||| S:1171 E:1182 ||| NN
by  ||| S:1182 E:1185 ||| IN
PJT  ||| S:1185 E:1189 ||| NNP
may  ||| S:1189 E:1193 ||| MD
have  ||| S:1193 E:1198 ||| VB
potential  ||| S:1198 E:1208 ||| JJ
value  ||| S:1208 E:1214 ||| NN
as  ||| S:1214 E:1217 ||| IN
a  ||| S:1217 E:1219 ||| DT
therapy  ||| S:1219 E:1227 ||| NN
for  ||| S:1227 E:1231 ||| IN
restricting  ||| S:1231 E:1243 ||| VBG
the  ||| S:1243 E:1247 ||| DT
invasiveness  ||| S:1247 E:1260 ||| NN
of  ||| S:1260 E:1263 ||| IN
breast  ||| S:1263 E:1270 ||| JJ
cancer ||| S:1270 E:1276 ||| NN
.  ||| S:1276 E:1278 ||| .
